Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

被引：0
|
作者：
Pia Wegman
Sauli Elingarami
John Carstensen
Olle Stål
Bo Nordenskjöld
Sten Wingren
机构：
[1] Linköping University,Department of Biomedicine and Surgery, Division of Cell Biology, Faculty of Health Sciences
[2] Linköping University,Department of Health and Society, Faculty of Arts and Sciences
[3] Linköping University,Department of Biomedicine and Surgery, Division of Oncology, Faculty of Health Sciences
来源：
Breast Cancer Research | / 9卷
关键词：
Breast Cancer; Tamoxifen; Postmenopausal Patient; Tamoxifen Therapy; Homozygous Carrier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Effect of CYP2D6, CYP3A5, and MDR1 Genetic Polymorphisms on the Pharmacokinetics of Risperidone and Its Active Moiety
    Xiang, Qian
    Zhao, Xia
    Zhou, Ying
    Duan, Jing Li
    Cui, Yi Min
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (06): : 659 - 666
  • [42] Association between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment
    Park, Hyung Seok
    Choi, Ji-Yeob
    Lee, Mi-Jeong
    Park, Seho
    Yeo, Chang-Woo
    Lee, Sang Seop
    Shin, Jae-Gook
    Park, Byeong-Woo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (08) : 1007 - 1013
  • [43] Effects of CYP3A5 genetic polymorphism on the pharmacokinetics of tamsulosin in subjects with with CYP2D6*10/*10
    Byeon, Ji-Yeong
    Jang, Choon-Gon
    Lee, Seok-Yong
    PHARMACOTHERAPY, 2012, 32 (10): : E236 - E236
  • [44] Re: CYP2D6 Genotyping and the Use of Tamoxifen in Breast Cancer
    Province, Michael A.
    Klein, Teri E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (02):
  • [45] CYP2D6 GENOTYPING TO GUIDE USE OF TAMOXIFEN IN BREAST CANCER
    Irvin, William J., Jr.
    Weck, Karen E.
    Walko, Christine M.
    Ibrahim, Joseph G.
    Chiu, Wing. K.
    Dees, E. Claire
    Ogburn, Evan T.
    Desta, Zeruesenay
    Flockhart, David A.
    McLeod, Howard L.
    Evans, James P.
    Carey, Lisa A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S88 - S88
  • [46] Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients
    Sutiman, Natalia
    Lim, Joanne Siok Liu
    Muerdter, Thomas E.
    Singh, Onkar
    Cheung, Yin Bun
    Ng, Raymond Chee Hui
    Yap, Yoon Sim
    Wong, Nan Soon
    Ang, Peter Cher Siang
    Dent, Rebecca
    Schroth, Werner
    Schwab, Matthias
    Khor, Chiea Chuen
    Chowbay, Balram
    CLINICAL PHARMACOKINETICS, 2016, 55 (10) : 1239 - 1250
  • [47] Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients
    Natalia Sutiman
    Joanne Siok Liu Lim
    Thomas E. Muerdter
    Onkar Singh
    Yin Bun Cheung
    Raymond Chee Hui Ng
    Yoon Sim Yap
    Nan Soon Wong
    Peter Cher Siang Ang
    Rebecca Dent
    Werner Schroth
    Matthias Schwab
    Chiea Chuen Khor
    Balram Chowbay
    Clinical Pharmacokinetics, 2016, 55 : 1239 - 1250
  • [48] The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1
    L. K. Teh
    N. I. Mohamed
    M. Z. Salleh
    M. Rohaizak
    N. S. Shahrun
    J. J. Saladina
    J. K. S. Shia
    H. Roslan
    S. Sood
    T. S. Rajoo
    S. P. Muniandy
    G. Henry
    H. A. Ngow
    K. T. Hla U
    J. Din
    The AAPS Journal, 2012, 14 : 52 - 59
  • [49] The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1
    Teh, L. K.
    Mohamed, N. I.
    Salleh, M. Z.
    Rohaizak, M.
    Shahrun, N. S.
    Saladina, J. J.
    Shia, J. K. S.
    Roslan, H.
    Sood, S.
    Rajoo, T. S.
    Muniandy, S. P.
    Henry, G.
    Ngow, H. A.
    Hla U, K. T.
    Din, J.
    AAPS JOURNAL, 2012, 14 (01): : 52 - 59
  • [50] Impact of the CYP2D6 phenotype on the outcome of breast cancer patients treated with tamoxifen
    Dorado, Pedro
    Penas-Lledo, Eva
    LLerena, Adrian
    PHARMACOGENOMICS, 2013, 14 (06) : 606 - 606
12345